Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | UBE2M | P61081 | 1/20 | 0.36 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4494003 | 0.90 | LSS (0.40) | LSSKDM4EMAPTMAPK1EGLN2 | |
| SCHEMBL976567 | 0.81 | KDM4E (0.48) | ENPP1KDM4EMAPTMAPK1ALDH1A1 | |
| SCHEMBL3217162 | 0.81 | KDM4E (0.42) | ENPP1KDM4EMAPTMAPK1ALDH1A1 | |
| SCHEMBL3227902 | 0.79 | KDM4E (0.46) | ENPP1KDM4EMAPTMAPK1ALDH1A1 | |
| SCHEMBL3223559 | 0.77 | PDE2A (0.38) | EGLN2 | |
| SCHEMBL4815261 | 0.77 | KDM4E (0.40) | KDM4EMAPTMAPK1UBE2MDCUN1D1 | |
| SCHEMBL4820837 | 0.77 | KDM4E (0.41) | KDM4EMAPTMAPK1ALDH1A1POLB | |
| SCHEMBL4492293 | 0.77 | ALDH1A1 (0.37) | KDM4EMAPTMAPK1ALDH1A1POLB | |
| SCHEMBL4475964 | 0.76 | ALDH1A1 (0.42) | KDM4EMAPTMAPK1HRH3ALDH1A1 | |
| SCHEMBL7000548 | 0.74 | KDM4E (0.42) | ENPP1KDM4EMAPTMAPK1UBE2M |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056371-A1 | Use of Azolopyrimidines for Controlling Phytopathogenic Harmful Fungi | BASF SE (DE) | 2010-03-04 | — | — | US | disclosed |
| EP-2117312-A1 | USE OF AZOLOPYRIMIDINES FOR FIGHTING PLANT PATHOGENIC FUNGI | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008084027-A1 | USE OF AZOLOPYRIMIDINES FOR FIGHTING PLANT PATHOGENIC FUNGI | BASF SE (DE) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056371-A1 | Use of Azolopyrimidines for Controlling Phytopathogenic Harmful Fungi | DPM1, TYMP, G6PD | LSS 469/4885ENPP1 184/4885KDM4E 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.